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Testicular germ cell tumors (TGCTs) of adolescents
and adults have been shown to contain proteins of
the human endogenous retrovirus type K family. In a
recent study, expression of these retroviral se-
quences was confirmed using in situ hybridization,
which also showed expression in carcinoma in situ ,
the precursor of all TGCTs. Because of the clinical
significance of a test for early diagnosis of TGCTs, we
studied whether expression of human endogenous
retrovirus type K genes could be an informative pa-
rameter. Therefore, we investigated TGCTs of various
histologies and testicular parenchyma with and with-
out carcinoma in situ using reverse transcription-
polymerase chain reaction for expression of the gag ,
env , and prt genes. The gag and prt genes were ex-
pressed in all samples tested. The env transcripts
were not found in TGCTs showing somatic differenti-
ation only but could be detected in most normal tes-
ticular parenchyma samples. Therefore, detection of
human endogenous retrovirus type K transcripts can-
not be used for early diagnosis of TGCTs. Simulta-
neous expression of multiple gag sequences was
found both in normal parenchyma and TGCTs, and
we demonstrated that expression of gag sequences
with an extra G, necessary to generate a functional
protein, was not limited to TGCTs. (Am J Pathol
1998, 153:1277–1282)
Testicular germ cell tumors (TGCTs) of adolescents and
adults are divided into two clinically and histologically
distinct entities: the seminomas and the nonseminoma-
tous TGCTs.1–3 The seminomas are composed of neo-
plastic primitive germ cells. Nonseminomatous TGCTs
are neoplastic caricatures of early development and may
be composed of a stem cell population of embryonal
carcinoma, giving rise to teratoma (somatic tissue) and
yolk sac tumor and choriocarcinoma (extraembryonic tis-
sues).4 Seminomas and nonseminomatous TGCTs origi-
nate from a common precursor known as carcinoma in
situ (CIS)5 or intratubular germ cell neoplasia.6 Epidemi-
ological data and histological findings indicate that CIS is
formed during intrauterine development7,8 and will al-
ways progress to an invasive cancer.9
TGCTs are the most common cancer in Caucasian
males between 15 and 45 years of age. For most Euro-
pean countries, as well as the USA, an increasing inci-
dence has been reported.10–12 Several well defined risk
factors, among them a familial history, have been identi-
fied for this cancer.13–16 Up to about 90% of the invasive
TGCTs can be cured using orchidectomy alone or in
combination with irradiation and/or chemotherapy.2 CIS,
however, can be effectively treated by low-dose irradia-
tion with minimal side effects.17 This treatment prevents
the development of an invasive TGCT, underscoring the
clinical relevance of a sensitive and specific marker for
CIS.
The presence of human endogenous retrovirus type K
(HERV-K) proteins in TGCTs has been recognized for
several years.18 Patients with a TGCT frequently show a
specific immune response to these proteins.18,19 Using in
situ hybridization, Herbst et al20 showed that the gag and
env genes of HERV-K are expressed in all histological
elements of TGCTs, except teratoma. Expression of
HERV-K genes was also detected in CIS, whereas normal
cells of the testis were negative. These data suggest that
transcripts of HERV-K-specific genes, such as gag and
env, could be used as a marker for TGCTs, in particular
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for diagnosis of CIS. To test this hypothesis, we devel-
oped a reverse transcription polymerase chain reaction
(RT-PCR) for gag, env, and prt expression. A series of
invasive TGCTs with different histologies, testicular pa-
renchyma with varying amounts of CIS, and normal tes-
ticular parenchyma were studied. In addition, we show
that multiple gag sequences are simultaneously ex-
pressed in TGCTs and in normal testicular parenchyma.
At variance with previous findings, we show that expres-
sion of a specific gag variant, containing an extra G, is not
unique for TGCTs. We conclude that detection of HERV-K
transcripts cannot be used for early diagnosis of TGCTs.
Materials and Methods
Tissue Samples
Tumor and parenchyma was sampled from orchidectomy
specimens with TGCTs and nonneoplastic conditions
collected at the pathology departments of collaborating
hospitals. Representative samples were divided into two
parts; one was immediately snap frozen in liquid nitrogen,
and the other was formalin-fixed and paraffin-embedded.
Samples of normal testicular parenchyma obtained from
autopsies of men who died from causes other than tes-
ticular cancer were processed in the same way. TGCTs
were classified on the basis of morphology and immuno-
histochemistry according to the World Health Organiza-
tion classification.3 The presence of CIS was visualized
on acetone-fixed, frozen tissue sections using a direct
enzyme-histochemical staining method, as previously
described.21 The percentage of seminiferous tubules
containing CIS was scored.
RNA Isolation and RT-PCR
Total RNA was isolated from 10 to 15 frozen tissue sec-
tions of 20-mm thickness using RNAzol (Tel-Test Inc,
Friendswood, TX). The first and last tissue section of the
series was stained with hematoxylin and eosin (H&E) for
histological evaluation.
All samples were treated with DNase. Since the viral
sequences of interest lack introns, cDNA synthesis reac-
tions were performed with (1) and without (2) addition of
the reverse transcriptase enzyme according to standard
procedures using both oligo(dT) and random hexamers
as described before.22 The results were only interpreted
when the (2) sample lacked amplification products. PCR
was performed on the equivalent of 125 ng of total RNA
for the core protein gene (gag) (primers 59-AGAAG-
GAAAAGGTCCAGAATTA-39 AND 59-AGACTTGTATCT-
GGCCTCAACT-39; Tanneal 5 62°C, 35 cycles), the trans-
membrane region of the envelope gene (env-TM)
(primers 59-GCTGTAGCAGGAGTTGCATTG-39 and 59-
TAATCGATGTACTTCCAATGGTC-39; Tanneal 5 58°C, 35
cycles), and the protease (prt) (primers 59-TACAAG-
CAGTCTCTCTGCTTC-39 and 59-GCATGGTGATTTCCG-
CACCC-39; Tanneal 5 62°C, 35 cycles), resulting in PCR
products corresponding to nucleotides 1600 to 2037,
7900 to 8362, and 3124 to 3765, with reference to the
HERV-K10(1) sequence,23 respectively. For RNA quality
control, amplification of transcripts of the human hypo-
xanthine phosphoribosyltransferase gene was performed
on the same cDNA batch (primers 244 and 24324 (Tanneal
5 62°C, 28 cycles), generating a fragment of 387 bp). All
experiments were performed at least twice.
Sequencing and Subcloning
For direct sequencing of the RT-PCR products, the com-
mercially available AmpliCycle kit (Roche Molecular Sys-
tems, Inc., Branchburg) was applied, using 33P-labeled
primers. Fragment separation was performed on a 6%
acrylamid gel (mono:bis 5 29:1). All experiments were
performed twice.
Amplification products were subcloned by TA cloning,
using a prokaryotic TA cloning kit (Invitrogen, San Diego,
CA).
Results
We developed a specific RT-PCR to detect expression of
the HERV-K genes gag, env, and prt. The primers for
amplification of the gag and env sequences were de-
signed such that the amplification products show overlap
with at least one of the probes used for mRNA in situ
hybridization as described by Herbst et al.20 Using this
approach, we studied samples of normal testicular pa-
renchyma; pathological parenchyma with and without
CIS; and invasive TGCTs of different histologies, includ-
ing seminoma, embryonal carcinoma, yolk sac tumor,
teratoma, and nonseminomatous TGCT with mixed his-
tologies. Representative examples of the different histol-
ogies included in this study are demonstrated in Figure 1.
Representative examples of RT-PCR analysis for the gag
and env transcripts are given in Figure 2, and the results
are summarized in Table 1. To exclude DNA contamina-
tion, all RNA samples were pretreated with DNase before
cDNA synthesis (see Materials and Methods), which is
crucial because the HERV-K genes lack introns. Absence
of DNA was checked by RT-PCR analysis of the samples
with and without reverse transcriptase treatment. Be-
cause no amplification products were observed in the
samples without reverse transcriptase (not shown), the
PCR products in the samples treated with reverse tran-
scriptase indeed represent RNA. All samples were pos-
itive for the prt and gag transcripts. Although our method
does not allow a quantitative interpretation of the levels of
expression, there seems to be a tendency toward higher
expression of the gag gene in invasive TGCTs and in
testicular parenchyma containing CIS compared with
normal testicular parenchyma. Because of the possible
decline in RNA quality of samples obtained from autop-
sies, we also tested a parenchyma sample adjacent to a
Leydig cell tumor, which was immediately snap frozen
upon surgical removal, like the other pathological spec-
imens. This sample showed the same level of expression
as normal parenchyma, which also demonstrates that the
level of expression is not related to the presence of a
1278 Roelofs et al
AJP October 1998, Vol. 153, No. 4
malignancy in that testis per se. Testicular parenchyma
adjacent to a spermatocytic seminoma25 showed a
somewhat higher expression, which might be due to the
presence of intratubular spermatocytic seminoma dem-
onstrated in this sample. env transcripts were detected in
all testicular parenchyma samples containing varying
amounts of CIS, as well as all invasive TGCTs, except for
the three pure teratomas. These transcripts were also
found in the majority of normal testicular parenchyma
samples.
Figure 1. Representative examples of the various histologies included in this study, stained with H&E: normal testicular parenchyma (A), atrophic testicular
parenchyma (B), testicular parenchyma with CIS (C), seminoma (D), embryonal carcinoma (E), yolk sac tumor (F), and mature teratoma (G). Magnification, 3160.
HERV-K Expression in Germ Cell Neoplasia 1279
AJP October 1998, Vol. 153, No. 4
The identity of the amplification products was con-
firmed by direct sequencing. Specifically, the expressed
gag sequences of all four normal testicular parenchyma
samples and two seminomas were analyzed, and the env
sequences of two of the normal parenchyma samples as
well as both seminomas were determined. Within the
region of the gag gene analyzed, a number of base
differences were detected in comparison with the pub-
lished HERV sequence,23 which are indicated in Figure 3.
Moreover, at several positions in this sequence, multiple
bases were found, which suggests that several HERV
transcripts were present. To test whether expression of
specific HERV sequences could provide a basis to de-
velop a strategy for early diagnosis of TGCTs, we se-
quenced several independent RT-PCR products. The
gag products of one normal testicular parenchyma sam-
ple and one seminoma were cloned, and subsequently
five and two individual subclones were sequenced, re-
spectively. Representative findings are shown in Figure
4, demonstrating the presence of different sequences
within the various subclones. This finding confirms the
simultaneous presence of multiple HERV transcripts,
both in normal parenchyma and seminoma. There was,
however, no transcript found to be specific for the TGCT
that might be suitable as marker for early diagnosis. In
addition, the sequence analyses demonstrated that the
extra G after position 1749 (indicated by an asterisk in
Figure 4), which restores the open reading frame of the
gag gene,26 is not specific for TGCTs, but is also present
in normal testicular parenchyma (see also Figure 3). In
contrast to the gag sequences, no differences were found
between the expressed env sequences determined by us
in testicular parenchyma and seminoma and the pub-
lished sequence.23
Discussion
Sequences of endogenous retroviruses, which are nor-
mally present within the genome, show structural and
sequence similarities to exogenous retroviruses. Al-
though a pathogenic potential has been shown for a
number of exogenous retroviruses in both mice and hu-
mans, this has only been reported in mice for endoge-
nous retroviruses.27 The pathogenic importance of
HERVs is questionable, because these sequences are
defective due to multiple termination codons, preventing
generation of functional proteins.28,29 A possible excep-
tion is HERV-K, for which intact open reading frames and
functional proteins have been identified.18,26,30,31 Inter-
estingly, proteins encoded by these sequences, in par-
ticular gag, have been found in TGCTs, and antibodies
against gag and env proteins have been detected in
serum of patients with these tumors.18,19 Expression of
HERV-K genes gag and env in TGCTs was recently con-
firmed using in situ hybridization.20 This study added the
finding that these transcripts are also present in CIS, the
precursor of all TGCTs. If expression of these genes is
specific for TGCTs, including CIS, they might be a proper
target for early diagnosis of this cancer. Because mRNA
in situ hybridization is not suitable for routine application
in a clinical setting, we developed an RT-PCR to detect
HERV-K-specific transcripts. Although a more heteroge-
neous pattern was identified for the env gene, we basi-
cally found expression of all tested HERV-K genes in
normal testicular parenchyma. Therefore, we have to
conclude that detection of HERV-K transcripts by means
of PCR cannot be used for early diagnosis of TGCTs.
Although the quality of RNA from autopsy samples can
be argued, this is not of relevance in this particular con-
text, because expression was found. The explanation for
the observation that in situ hybridization, as performed by
Herbst et al,20 does not reveal expression of the gag and
env genes in normal testicular parenchyma is most likely
the lower sensitivity of the technique. This is in agreement
with the lower level of expression we detected in normal
testicular parenchyma compared with the level in paren-
chyma containing CIS and most invasive TGCTs. Al-
though mRNA in situ hybridization demonstrated rather
clear differences in gag and env expression levels be-
tween some histological variants of TGCTs and normal
testicular parenchyma, our RT-PCR showed a less differ-
entiated pattern. This can be attributed to the fact that
total RNA is used for the latter approach. Whereas the in
situ approach elegantly demonstrates the number of tran-
Figure 2. Representative examples of RT-PCR analysis of expression of the
gag and env genes in normal testicular parenchyma (N), parenchyma adja-
cent to a Leydig cell tumor (N/Leyd) and a spermatocytic seminoma (N/SS),
as well as parenchyma adjacent to a testicular germ cell tumor of adolescents
and adults containing CIS. Also shown is RT-PCR analysis of gag and env
expression in invasive tumor, with the histology of seminoma (SE), embry-
onal carcinoma (EC), yolk sac tumor (YS), mature teratoma (MT), and mixed
nonseminomas (NS (mix)). In addition, a negative (H2O) control is indi-
cated. As RNA quality control, expression of the human hypoxanthine phos-
phoribosyltransferase (HPRT) is shown.
Table 1. Summary of the Results of RT-PCR Polymerase
Chain Reaction-Based Detection of Expression of
the prt, gag, and env genes in Normal and
Pathological Testicular Parenchyma, as Well as
Testicular Germ Cell Tumors of Adolescents and
Adults of Various Histologies (Numbers of Positives
Per Cases Tested Are Indicated)
Tissue* prt gag env
N 4/4 7/7 5/7
N/Leyd 1/1 1/1
N/SS 1/1 1/1
CIS (low) 2/2 2/2
CIS (high) 3/3 4/4 4/4
SE 5/5 5/5 3/3
EC 3/3 3/3
YS 3/3 3/3
MT 3/3 0/3
NS (mix) 3/3 3/3
*Abbreviations are as indicated in the legend to Figure 2. CIS (low)
indicates that fewer than 20% of the seminiferous tubules contain CIS
cells, and CIS (high) accounts for more than 50%.
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scripts per cell in their histological context, RT-PCR re-
sults in information about the overall level of expression in
a particular sample. Tissue samples are composed of a
mixture of both malignant and normal host cells. Further-
more, there is usually a vast intrasample variation in
expression of HERV-K genes, which might be due to cell
cycle-dependent regulation, as suggested before.20
These factors influence the overall expression level and
result in relatively modest differences between the sam-
ples. The intensity of an immune response against
HERV-K proteins, which is almost invariably found in
patients with a TGCT, cannot directly be related to the
expression level of their genes, because an immune re-
sponse is determined by the proteins, not by the tran-
scripts, and the immunogenicity of a protein is not deter-
mined by its level of presence only.
It has been estimated that, within the human genome,
approximately 50 copies of HERV-K sequences are
present.32 They can differ in sequence and are poten-
tially all expressed. Our sequencing results indeed dem-
onstrate that multiple gag sequences are expressed si-
multaneously, both in TGCTs and normal testicular
parenchyma. No conclusion can be drawn about env,
because the region studied might lack differences be-
tween the various genes present. Our data therefore
suggest that at least multiple gag genes are upregulated
in TGCTs.
In agreement with the results described by Herbst et
al,20 we detected no env-specific transcripts in TGCTs
that are somatically differentiated. However, we still de-
tected expression of gag genes in these samples, which
indicates that a selection of HERV-K genes is downregu-
lated upon somatic differentiation. Inhibition of expres-
sion of genes of this kind in human cells upon somatic
differentiation is not unique. For example, a similar ob-
servation has been made for LINE-1 sequences. These
retrotransposons are only expressed in primary TGCTs
and TGCT-derived cell lines with the histology of embry-
onal carcinoma and/or yolk sac.33–36 No LINE-1 gene
expression has been found in teratomas.33,34 These data
indicate that absence of expression of HERV-K genes in
teratoma, in particular env (this study), might be a more
general phenomenon related to differentiation. In our
view, the hypothesis of Herbst et al20 that teratoma is less
closely related to embryonal carcinoma than seminoma,
is not correct, which is supported both by clinical and
experimental findings.4,37–39
An extra single base (G) after position 1749 of the gag
gene found in a TGCT-derived cell line causes a frame
shift necessary to generate a functional protein.26 In ac-
cordance, this particular cell line shows expression of
HERV-K genes and produces retrovirus particles. We
found this particular G base not only in the gag transcripts
of different independent TGCTs; it was also present in
transcripts from normal testicular parenchyma. These
data indicate that generation of a functional gag protein is
not restricted to TGCTs.
In conclusion, our results show that detection of
HERV-K transcripts by means of PCR cannot be applied
for early diagnosis of TGCTs. In addition, we demon-
strated that multiple HERV-K gag genes are expressed
simultaneously in normal testicular parenchyma and
TGCTs, and that not all HERV-K genes show downregu-
lation upon somatic differentiation. Moreover, our results
indicate that the formation of a functional gag protein is
not restricted to TGCTs.
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Figure 3. Summary of the sequence analyses of
the expressed gag genes after direct sequenc-
ing of the amplification products derived from
four independent normal testicular paren-
chyma samples (N1 to N4) and two seminomas
(Se1 and Se2). Note the extra G base after
position 1749. Abbreviations used: R 5 A/G,
S 5 C/G, H 5 A/C/T, W 5 A/T, Y 5 C/T, K 5
G/T, and N 5 G/A/T/C.
Figure 4. Representative examples of expressed gag sequences of one nor-
mal testicular parenchyma and one seminoma. Note the difference in se-
quence of the subclones. In addition, the extra G base after position 1749 of
the original sequence is indicated with an asterisk.
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